GSK was warned repeatedly about Zantac impurity but played down risks: Bloomberg

Facing tens of thousands of lawsuits over cancer risks on the popular heartburn drug Zantac, GSK has argued there’s “no consistent or reliable …

Share on Facebook

Tweet

Follow us

Save